- Home
- THAR vs CREV Comparison
THAR vs CREV Comparison
Compare THAR & CREV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- CREV
- Stock Information
- Founded
- THAR 2017
- CREV 2007
- Country
- THAR United States
- CREV Ireland
- Employees
- THAR 3
- CREV N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- CREV
- Sector
- THAR Health Care
- CREV
- Exchange
- THAR Nasdaq
- CREV Nasdaq
- Market Cap
- THAR 16.8M
- CREV 6.0M
- IPO Year
- THAR 2022
- CREV N/A
- Fundamental
- Price
- THAR $3.14
- CREV $4.05
- Analyst Decision
- THAR Strong Buy
- CREV
- Analyst Count
- THAR 1
- CREV 0
- Target Price
- THAR $17.00
- CREV N/A
- AVG Volume (30 Days)
- THAR 29.4M
- CREV 32.6K
- Earning Date
- THAR 11-06-2025
- CREV 05-14-2025
- Dividend Yield
- THAR N/A
- CREV N/A
- EPS Growth
- THAR N/A
- CREV N/A
- EPS
- THAR N/A
- CREV N/A
- Revenue
- THAR N/A
- CREV $39,261,077.00
- Revenue This Year
- THAR N/A
- CREV $40.76
- Revenue Next Year
- THAR N/A
- CREV $86.18
- P/E Ratio
- THAR N/A
- CREV N/A
- Revenue Growth
- THAR N/A
- CREV 41.52
- 52 Week Low
- THAR $0.95
- CREV $2.00
- 52 Week High
- THAR $9.08
- CREV $12.75
- Technical
- Relative Strength Index (RSI)
- THAR 48.05
- CREV 46.48
- Support Level
- THAR $2.75
- CREV $3.90
- Resistance Level
- THAR $3.46
- CREV $4.32
- Average True Range (ATR)
- THAR 1.23
- CREV 0.36
- MACD
- THAR -0.32
- CREV -0.03
- Stochastic Oscillator
- THAR 6.16
- CREV 25.38
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About CREV Carbon Revolution Public Limited
Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.